News

Ideas That Generate Results

India has emerged as a key destination for conducting clinical trials. The country is getting preference mainly because of rich patient pool suffering from chronic diseases such as cancer and diabetes. As per our research report "Booming Clinical Trials Market in India", it is expected that the number of clinical studies will grow at a CAGR of over 14% in the next three years.

The new research has done an extensive study of the clinical trials industry in India. The study has found low cost as one of the most important aspect of India compared to other countries in the same field. We have also done a thorough cost and situational analysis of various phases of the clinical trials in India compared to not just western countries but also with other rapidly emerging clinical trials markets such as Russia and Brazil.

We have also identified key areas which will serve as benchmark for the growth of clinical trial industry in India. Our research report provides in-depth analysis of these areas while examining and explaining their importance in the industry development. Our industry analysis observes that there are various emerging market trends like clinical data management, pathology and diagnostic market which are developing in line with the growth in clinical trial market. Each of these market trends have been extensively covered in our report.  

We believe that the regulatory environment plays a significant role in the development of clinical trials industry and our research provides a broad view of the regulatory environment in India. We have also studied the regulatory restraints and suggested recommendation which will prove beneficial to both client and the industry.

"Booming Clinical Trials Market in India" also provides information of the key competitors in the market along with their operations and areas of expertise. This will help the client in understanding the market in a better way and provide an additional edge over other competitors in the market.

For more information visit: http://www.rncos.com/Report/IM564.htm